Pharmacokinetics of gallium maltolate after intragastric administration in neonatal foals

American Journal of Veterinary Research

Volumn 68, Issue 10, 2007, Pages 1041-1044

  Martens, Ronald J ^a   Mealey, Katrina ^b   Cohen, Noah D ^a   Harrington, Jessica R ^a   Chaffin, M Keith ^a   Taylor, Robert J ^a   Bernstein, Lawrence R ^c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b WASHINGTON STATE UNIVERSITY   (United States)

^c Terrametrix   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; GALLIUM; GALLIUM MALTOLATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; MACROPHAGE; MALE; MASS SPECTROMETRY; MEAN RESIDENCE TIME; NASOGASTRIC TUBE; NEWBORN; NONHUMAN; RHODOCOCCUS EQUI; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ANIMALS; ANIMALS, NEWBORN; AREA UNDER CURVE; GALLIUM; HORSES; KINETICS; ORGANOMETALLIC COMPOUNDS; PYRONES;

ANIMALIA; RHODOCOCCUS EQUI;

EID: 35448933262     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.68.10.1041     Document Type: Article

References (21)

1. Hondalus MK, Mosser DM. Survival and replication of Rhodococcus equi in macrophages. Infect Immun 1994;62:4167-4175.
2. Giguere S, Prescott JF. Clinical manifestations, diagnosis, treatment, and prevention of Rhodococcus equi infections in foals. Vet Microbiol 1997;56:313-334.
3. Weinstock DM, Brown AE. Rhodococcus equi: an emerging pathogen. Clin Infect Dis 2002;34:1379-1385.
4. Horowitz ML, Cohen ND, Takai S, et al. Application of Sartwell's model (logarithmic-normal distribution of incubation periods) to age at onset and age at death of foals with Rhodococcus equi pneumonia as evidence of perinatal infection. J Vet Intern Med 2001;15:171-175.
5. Martens JG, Martens RJ, Renshaw HW. Rhodococcus (Corynebacterium) ectui: bactericidal capacity of neutrophils from neonatal and adult horses. Am J Vet Res 1988;49:295-299.
6. Boyd NK, Cohen ND, Lim WS, et al. Temporal changes in cytokine expression of foals during the first month of life. Vet Immunol Immunopathol 2003;92:75-85.
7. Chaffin MK, Cohen ND, Martens RJ, et al. Hematologic and immunophenotypic factors associated with the development of Rhodococcus equi pneumonia of foals at equine breeding farms with endemic infection. Vet Immunol Immunopathol 2004;100:33-48.
8. Breathnach CC, Sturgill-Wright T, Stiltner JL, et al. Foals are interferon gamma-deficient at birth. Vet Immunol Immunopathol 2006;112:199-209.
9. Jordan MC, Harrington JR, Cohen ND, et al. Effects of iron modulation on growth and viability of Rhodococcus equi and expression of virulence-associated protein A. Am J Vet Res 2003;64:1337-1346.
10. Harrington JR, Martens RJ, Cohen ND, et al. Antimicrobial activity of gallium against virulent Rhodococcus equi in vitro and in vivo. J Vet Pharmacol Ther 2006;29:121-127.
11. Weinberg GA. Iron chelators as therapeutic agents against Pneumocystis carinii. Antimicrob Agents Chemother 1994; 38:997-1003.
12. Byrd TF, Horwitz MA. Chloroquine inhibits the intracellular multiplication of Legionella pneumophilia by limiting the available iron. J Clin Invest 1991;88:351-357.
13. Kaneko Y, Thoendel M, Olakanmi O, et al. The transition metal gallium disrupts Pseudomonas aeruginosa iron metabolism and has antimicrobial and antibiofilm activity. J Clin Invest 2007;117:877-888.
14. Bernstein LR. Mechanisms of therapeutic activity for gallium. Pharmacol Rev 1998;50:665-682.
15. Olakanmi O, Britigan B, Schlesinger L. Gallium disrupts iron metabolism of mycobacteria residing within human macrophages. Infect Immun 2000;68:5619-5627.
16. Bernstein LR, Tanner T, Godfrey C, et al. Chemistry and pharmacokinetics of gallium maltolate, a compound with high oral gallium bioavailability. Met Based Drugs 2000;7:33-47.
17. Tsan MF. Mechanism of gallium-67 accumulation in inflammatory lesions. J Nucl Med 1986;26:88-92.
18. Begin R, Bisson G, Lambert R, et al. Gallium-67 uptake in the lung of asbestos exposed sheep: early association with enhanced macrophage-derived fibronectin accumulation. J Nucl Med 196;27:538-544.
19. Chitambar CR, Zivkovi Z. Uptake of gallium-67 by human leukemic cells: demonstration of transferrin receptor-dependent and transferrin-independent mechanisms. Cancer Res 1987;47:3929-3934.
20. Martens RJ, Miller NA, Cohen ND, et al. Chemoprophylactic antimicrobial activity of gallium maltolate against intracellular Rhodococcus equi. J Equine Vet Sci 2007;27:341-345.
21. Bernstein LR. Therapeutic gallium compounds. In: Gielen M, Tiekink ERT, eds. Metallotherapeutic drugs and metal-based diagnostic agents: the use of metal in medicine. New York: John Wiley & Sons Ltd, 2005;259-277.